Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2013-08-13 / Cryobiology 2013 Oct;67(2):235-40In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer
/in Cervical Cancer, Dendritic Cells, International Publications /von 2013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-62Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer
/in Dendritic Cells, Hyperthermia, International Publications /von 2013-08-01 / Immunology 2013 Aug;139(4):407-15Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium
/in Breast Cancer, Dendritic Cells, International Publications /von 2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9Current status and future perspectives of dendritic cell-based cancer immunotherapy
/in Dendritic Cells, International Publications /von 2013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-71
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de